Actavis receives US FDA nod to market Bupropion tabs
Friday, July 23, 2010 10:00 IST Hafnarfjordur, Iceland
Actavis has received approval from US Food and Drug Administration (US FDA) to market Bupropion HCl Extended-Release (SR) tablets 100mg and 200mg. Distribution of the product will commence immediately.